AOD-9604 in Caibi — Fat Loss Peptide Research Guide
AOD-9604 research guide for Caibi. HGH fragment studied for fat metabolism — covers mechanism, purity standards, COA verification, and how to source AOD-9604.
For anyone in Caibi looking to source AOD-9604, the first thing to know is that this compound is distributed via specialist online vendors. This matters because AOD-9604 quality differs enormously across the market — from analytically confirmed high-purity product to products with serious contamination — and the vendor controls every quality variable. Separating properly characterised AOD-9604 from the rest of the market comes down to three things: an HPLC chromatogram confirming ≥98% purity, mass spec data verifying the correct molecular weight, and a batch-specific endotoxin panel. The sections below cover what Caibi researchers need to know about sourcing, verifying, and handling AOD-9604 for scientific research use.
How AOD-9604 Works — Mechanisms & Research
The selectivity profile of different GHS compounds is a critical research consideration. GHRP-6 and GHRP-2 produce GH release alongside cortisol and prolactin elevation — a confounding factor in research designs where these hormones are outcome variables. Ipamorelin was specifically developed for greater GH-release selectivity with minimal cortisol and prolactin elevation, making it more suitable for research designs where GH-specific effects need to be isolated. Hexarelin has the strongest GH-releasing potency in the GHRP class but also the most significant cortisol and prolactin effects. For Caibi researchers designing GH-axis studies, compound selection based on this selectivity profile should precede protocol finalization.
AOD-9604 Purchasing Guide
The first step for any Caibi researcher sourcing AOD-9604 is identifying 2-3 vendors with documented positive community reputations — organic rankings are no guide to actual AOD-9604 quality. Endotoxin testing in the COA is critical for any injectable research use — endotoxins from bacterial cell wall components can trigger severe inflammatory responses even at very low concentrations. Strong quality indicators beyond COA quality: established track record of at least two years, knowledgeable support capable of explaining COA data, and shipping with desiccant and appropriate cold protection. Keep lyophilised AOD-9604 at freezer temperature (−20°C) until ready to use; reconstitute only the quantity required for your immediate research and keep the remainder frozen.
Order AOD-9604 — ships to Caibi
COA-verified · International tracking · Research grade
As a research compound, AOD-9604 has not been through the clinical trial process required for pharmaceutical approval — its safety profile is based on preclinical research and limited human studies. Lyophilised AOD-9604 should be frozen at −20°C as soon as it arrives; avoid repeatedly thawing and refreezing reconstituted peptide by preparing small aliquots before storage. The main safety concern arising from sourcing in AOD-9604 research is endotoxin contamination from poor sourcing — a verified endotoxin panel in the batch COA is the direct mitigation for this hazard. Protocol documentation — recording exactly what was used, when, and how — is a sound practice for any AOD-9604 protocol that makes anomalous results interpretable.
Frequently Asked Questions
What is the clinical trial history of AOD-9604?
AOD-9604 has undergone multiple Phase II clinical trials for obesity treatment by Metabolic Pharmaceuticals in Australia. The trials showed safety and tolerability but mixed efficacy results for weight loss. It holds GRAS (Generally Recognized As Safe) status from the FDA for food use, which is unusual for research peptides.
How does AOD-9604 differ from growth hormone?
AOD-9604 contains only the fat-metabolism-relevant fragment of growth hormone (the C-terminal region) without the IGF-1-stimulating N-terminal domain. This means it targets fat cells' beta-adrenergic receptors for lipolytic effects without producing the anabolic IGF-1 signaling associated with full-length GH.
What is AOD-9604?
AOD-9604 is a synthetic peptide analogue of the C-terminal fragment of human growth hormone (amino acids 177-191), with an additional tyrosine residue at the N-terminus. It has been studied for fat metabolism effects, specifically lipolysis stimulation and lipogenesis inhibition, without the IGF-1-stimulating effects of full-length GH. It has undergone clinical trials for obesity treatment.
